- €1.13bn
- €965.49m
- €741.18m
- 99
- 30
- 85
- 86
Annual cashflow statement for Neurones SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 35.2 | 35 | 42.9 | 51.8 | 58.6 |
| Depreciation | |||||
| Non-Cash Items | -3.51 | -0.068 | 1.88 | 2.72 | -1.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.4 | 16.4 | 5 | -16.1 | -1.58 |
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 61.3 | 67.3 | 64.5 | 55 | 72.1 |
| Capital Expenditures | -7.89 | -7.19 | -6.58 | -10.6 | -18 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.259 | -0.82 | -4.04 | -1.65 | -3.59 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.15 | -8.01 | -10.6 | -12.3 | -21.6 |
| Financing Cash Flow Items | -1.24 | 1.62 | -0.486 | -4.67 | 3.12 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.36 | -11.1 | -55.4 | -36.1 | -27.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 43.9 | 48 | -1.42 | 6.89 | 23.5 |